Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma

World Journal of Gastroenterology

Volumn 21, Issue 15, 2015, Pages 4680-4687

  Wang, Yang Kun ^a   Chen, Zhong ^b   Yun, Tian ^a   Li, Cong Yang ^c   Jiang, Bo ^d   Lv, Xue Xia ^a   Chu, Guang Hui ^a   Wang, Su Nan ^e   Yan, Hui ^a   Shi, Lei Feng ^a  

^a Department of Pathology 150th Luoyang Center Hospital   (China)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Department of Pathology 152nd Center Hospital   (China)

^d Department of Pathology 159th Center Hospital   (China)

^e School of Electronic and Computer Engineering   (China)

Author keywords

Fluorescence in situ hybridization; Gastric pathology; Human epidermal growth factor receptor 2; Immunohistochemistry; Stomach

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IRINOTECAN; OXALIPLATIN; TAXANE DERIVATIVE; TRASTUZUMAB; ANTINEOPLASTIC AGENT; ERBB2 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER CHEMOTHERAPY; CHROMOSOME 17; DRUG TARGETING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIXED TUMOR; OBSERVATIONAL STUDY; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; STAINING; STOMACH CARCINOMA; TREATMENT OUTCOME; ADULT; AGED; ANTAGONISTS AND INHIBITORS; CARCINOMA; CHEMISTRY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENETICS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS, COMPLEX AND MIXED; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; STOMACH NEOPLASMS; TIME FACTOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CARCINOMA; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS; TRASTUZUMAB; TREATMENT OUTCOME;

EID: 84928184574     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i15.4680     Document Type: Article

References (14)

1. García-García E, Gómez-Martín C, Angulo B, Conde E, Suárez-Gauthier A, Adrados M, Perna C, Rodríguez-Peralto JL, Hidalgo M, López-Ríos F. Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dualcolour silver in-situ hybridization method. Histopathology 2011; 59: 8-17 [PMID: 21771023 DOI: 10.1111/j.1365-2559.2011.03894.x]
2. Isinger-Ekstrand A, Johansson J, Ohlsson M, Francis P, Staaf J, Jönsson M, Borg A, Nilbert M. Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array - comparative genomic hybridization. Cancer Genet Cytogenet 2010; 200: 120-126 [PMID: 20620594 DOI: 10.1016/j.cancergencyto.2010.03.013]
3. Rondón-Lagos M, Verdun Di Cantogno L, Marchiò C, Rangel N, Payan-Gomez C, Gugliotta P, Botta C, Bussolati G, Ramírez-Clavijo SR, Pasini B, Sapino A. Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis. Mol Cytogenet 2014; 7: 8 [PMID: 24456987 DOI: 10.1186/1755-8166-7-8]
4. Gumuskaya B, Alper M, Hucumenoglu S, Altundag K, Uner A, Guler G. EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genet Cytogenet 2010; 203: 222-229 [PMID: 21156237 DOI: 10.1016/j.cancergencyto.2010.07.118]
5. Preusser M, Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Marosi C, Hejna M, Capper D, VON Deimling A, Schoppmann SF, Birner P. Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies. Anticancer Res 2013; 33: 1065-1071 [PMID: 23482783]
6. Gordon MA, Gundacker HM, Benedetti J, Macdonald JS, Baranda JC, Levin WJ, Blanke CD, Elatre W, Weng P, Zhou JY, Lenz HJ, Press MF. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 2013; 24: 1754-1761 [PMID: 23524864 DOI: 10.1093/annonc/mdt106]
7. Miyamae M, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Konishi H, Morimura R, Murayama Y, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Fujiwara H, Sakakura C, Otsuji E. [Discrepancies in the histological grade of submucosal gastric carcinoma between biopsy and postoperative resected specimens]. Gan To Kagaku Ryoho 2013; 40: 2292-2294 [PMID: 24394089]
8. Tanabe S, Aoyagi K, Yokozaki H, Sasaki H. Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition. Int J Oncol 2014; 44: 1955-1970 [PMID: 24728500 DOI: 10.3892/ijo.2014.2387]
9. Yk W, Cf G, T Y, Z C, Xw Z, Xx L, Nl M, Wz Z. Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization. Mol Cytogenet 2011; 4: 14 [PMID: 21689422 DOI: 10.1186/1755-8166-4-14]
10. Sanaat Z, Halimi M, Ghojezadeh M, Pirovi AH, Gharamaleki JV, Ziae AE, Kermani IA. Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran. Int J Hematol Oncol Stem Cell Res 2013; 7: 15-20 [PMID: 24505530]
11. Tajiri R, Ooi A, Fujimura T, Dobashi Y, Oyama T, Nakamura R, Ikeda H. Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization. Hum Pathol 2014; 45: 725-734 [PMID: 24491355 DOI: 10.1016/j.humpath.2013.11.004]
12. Kim MA, Jung EJ, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and realtime quantitative polymerase chain reaction. Hum Pathol 2007; 38: 1386-1393 [PMID: 17555797]
13. Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D, Hölscher AH, Danenberg PV. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res 2001; 7: 1850-1855 [PMID: 11448895]
14. Pala EE, Bayol U, Ozguzer A, Akman O. HER2 status in gastric cancer: a comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest™). Pathol Res Pract 2013; 209: 548-554 [PMID: 23910175 DOI: 10.1016/j.prp.2013.05.008]